Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Mohr

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
The Journal of Clinical Psychiatry|March 21, 1998
The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychoticsC H Miller, F Mohr, D Umbricht, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 5, 2023
Examining the Burden of Potentially Avoidable Heart Failure HospitalizationsMarya D Zilberberg, Brian H Nathanson, Kate Sulham, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1996
Neuropsychological impairment in first-episode and chronic schizophrenic patientsM Albus, W Hubmann, C Ehrenberg, et al.
Pharmacotherapy|September 28, 2005
A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxoneJohn F Mohr, Peggy S McKinnon, Patti J Peymann, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 31, 1998
Neuropsychological impairment and psychopathology in first-episode schizophrenic patients related to the early course of illnessJ Binder, M Albus, W Hubmann, et al.
Virology|September 13, 2015
Regulation of the tumor marker Fascin by the viral oncoprotein Tax of human T-cell leukemia virus type 1 (HTLV-1) depends on promoter activation and on a promoter-independent mechanismCaroline F Mohr, Christine Gross, Matthias Bros, et al.
Clinicoeconomics and Outcomes Research : CEOR|March 6, 2023
Descriptive Epidemiology and Outcomes of Patients with Short Stay Hospitalizations for the Treatment of Congestive Heart Failure in the USMarya D Zilberberg, Brian H Nathanson, Katherine Sulham, et al.
Schizophrenia Research|January 15, 1998
Are there gender differences in neuropsychological performance in patients with first-episode schizophrenia?M Albus, W Hubmann, F Mohr, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2004
Pharmacokinetics of intravenous itraconazole in stable hemodialysis patientsJohn F Mohr, Kevin W Finkel, John H Rex, et al.
Journal of Clinical Microbiology|November 5, 2010
Prospective survey of (1→3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit settingJohn F Mohr, Charles Sims, Victor Paetznick, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
The Journal of Clinical Psychiatry|March 21, 1998
The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychoticsC H Miller, F Mohr, D Umbricht, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 5, 2023
Examining the Burden of Potentially Avoidable Heart Failure HospitalizationsMarya D Zilberberg, Brian H Nathanson, Kate Sulham, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1996
Neuropsychological impairment in first-episode and chronic schizophrenic patientsM Albus, W Hubmann, C Ehrenberg, et al.
Pharmacotherapy|September 28, 2005
A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxoneJohn F Mohr, Peggy S McKinnon, Patti J Peymann, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 31, 1998
Neuropsychological impairment and psychopathology in first-episode schizophrenic patients related to the early course of illnessJ Binder, M Albus, W Hubmann, et al.
Virology|September 13, 2015
Regulation of the tumor marker Fascin by the viral oncoprotein Tax of human T-cell leukemia virus type 1 (HTLV-1) depends on promoter activation and on a promoter-independent mechanismCaroline F Mohr, Christine Gross, Matthias Bros, et al.
Clinicoeconomics and Outcomes Research : CEOR|March 6, 2023
Descriptive Epidemiology and Outcomes of Patients with Short Stay Hospitalizations for the Treatment of Congestive Heart Failure in the USMarya D Zilberberg, Brian H Nathanson, Katherine Sulham, et al.
Schizophrenia Research|January 15, 1998
Are there gender differences in neuropsychological performance in patients with first-episode schizophrenia?M Albus, W Hubmann, F Mohr, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2004
Pharmacokinetics of intravenous itraconazole in stable hemodialysis patientsJohn F Mohr, Kevin W Finkel, John H Rex, et al.
Journal of Clinical Microbiology|November 5, 2010
Prospective survey of (1→3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit settingJohn F Mohr, Charles Sims, Victor Paetznick, et al.
Pageof 8